1,687
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Diagnosing pancreatic cancer in general practice: a cross-sectional study on associations between suspicion of cancer, urgent referral and time to diagnosis

, , &
Pages 78-86 | Received 17 May 2021, Accepted 12 Nov 2021, Published online: 11 Feb 2022

References

  • Cronin-Fenton DP, Erichsen R, Mortensen FV, et al. Pancreatic cancer survival in Central and Northern Denmark from 1998 through 2009: a population-based cohort study. Clin Epidemiol. 2011;3(Suppl 1):19–25.
  • Kleeff J, Korc M, Apte M, et al. Pancreatic cancer. Nat Rev Dis Primers. 2016;2:16022.
  • Rasmussen LS, Fristrup CW, Jensen BV, et al. Initial treatment and survival in 4163 Danish patients with pancreatic cancer: a nationwide unselected real-world register study. Eur J Cancer. 2020;129:50–59.
  • Zhou B, Xu JW, Cheng YG, et al. Early detection of pancreatic cancer: where are we now and where are we going? Int J Cancer. 2017;141(2):231–241.
  • Elliss-Brookes L, McPhail S, Ives A, et al. Routes to diagnosis for cancer - determining the patient journey using multiple routine data sets. Br J Cancer. 2012;107(8):1220–1226.
  • Jooste V, Dejardin O, Bouvier V, et al. Pancreatic cancer: wait times from presentation to treatment and survival in a population-based study. Int J Cancer. 2016;139(5):1073–1080.
  • Probst HB, Hussain ZB, Andersen O. Cancer patient pathways in Denmark as a joint effort between bureaucrats, health professionals and politicians-a national Danish project. Health Policy. 2012;105(1):65–70.
  • Walter FM, Mills K, Mendonça SC, et al. Symptoms and patient factors associated with diagnostic intervals for pancreatic cancer (SYMPTOM pancreatic study): a prospective cohort study. The Lancet Gastroenterol Hepatol. 2016;1(4):298–306.
  • Jensen H, Torring ML, Olesen F, et al. Cancer suspicion in general practice, urgent referral and time to diagnosis: a population-based GP survey and registry study. BMC Cancer. 2014;14:636.
  • Neal RD, Din NU, Hamilton W, et al. Comparison of cancer diagnostic intervals before and after implementation of NICE guidelines: analysis of data from the UK general practice research database. Br J Cancer. 2014;110(3):584–592.
  • Garg SK, Chari ST. Early detection of pancreatic cancer. Curr Opin Gastroenterol. 2020;36(5):456–461.
  • Singhi AD, Koay EJ, Chari ST, et al. Early detection of pancreatic cancer: opportunities and challenges. Gastroenterology. 2019;156(7):2024–2040.
  • Lyratzopoulos G, Saunders CL, Abel GA, et al. The relative length of the patient and the primary care interval in patients with 28 common and rarer cancers. Br J Cancer. 2015;112:S35–S40.
  • Keeble S, Abel GA, Saunders CL, et al. Variation in promptness of presentation among 10,297 patients subsequently diagnosed with one of 18 cancers: evidence from a national audit of cancer diagnosis in primary care. Int J Cancer. 2014;135(5):1220–1228.
  • Pedersen KM, Andersen JS, Sondergaard J. General practice and primary health care in Denmark. J Am Board Fam Med. 2012;25 (Suppl 1):S34–S8.
  • Lynge E, Sandegaard JL, Rebolj M. The Danish national patient register. Scand J Public Health. 2011;39(7 Suppl):30–33.
  • Andersen JS, Olivarius F, Krasnik A. The Danish national health service register. Scand J Public Health. 2011;39(7 Suppl):34–37.
  • Weller D, Vedsted P, Rubin G, et al. The Aarhus statement: improving design and reporting of studies on early cancer diagnosis. Br J Cancer. 2012;106(7):1262–1267.
  • Pedersen CB. The Danish civil registration system. Scand J Public Health. 2011;39(7 Suppl):22–25.
  • Olivarius NF, Hollnagel H, Krasnik A, et al. The Danish national health service register. A tool for primary health care research. Dan Med Bull. 1997;44(4):449–453.
  • StataHacks. Pseudo percentiles 2019. [Assessed the 04.10.21. Available from: http://w.bruunisejs.dk/StataHacks/Datamanagement/pseudo_percentiles/pseudo_percentiles/.
  • Larsen MB, Jensen H, Hansen RP, et al. Identification of patients with incident cancers using administrative registry data. Dan Med J. 2014;61(2):A4777.
  • Lyratzopoulos G, Neal RD, Barbiere JM, et al. Variation in number of general practitioner consultations before hospital referral for cancer: findings from the 2010 national cancer patient experience survey in England. The Lancet Oncol. 2012;13(4):353–365.
  • Guldbrandt LM, Fenger-Gron M, Rasmussen TR, et al. The role of general practice in routes to diagnosis of lung cancer in Denmark: a population-based study of general practice involvement, diagnostic activity and diagnostic intervals. BMC Health Serv Res. 2015;15:21.
  • Baun ML, Jensen H, Falborg AZ, et al. Ovarian cancer suspicion, urgent referral and time to diagnosis in Danish general practice: a population-based study. Fam Pract. 2019;36(6):751–757.
  • Forrest LF, Sowden S, Rubin G, et al. Socio-economic inequalities in stage at diagnosis, and in time intervals on the lung cancer pathway from first symptom to treatment: systematic review and Meta-analysis. Thorax. 2017;72(5):430–436.
  • Forrest LF, Adams J, White M, et al. Factors associated with timeliness of post-primary care referral, diagnosis and treatment for lung cancer: population-based, data-linkage study. Br J Cancer. 2014;111(9):1843–1851.
  • Jensen H, Torring ML, Olesen F, et al. Diagnostic intervals before and after implementation of cancer patient pathways - a GP survey and registry based comparison of three cohorts of cancer patients. BMC Cancer. 2015;15(1):308–015.